TheraCryf
Phase 1TheraCryf is a clinical drug development company developing sulforaphane-based medicines focused on the treatment of cancer and inflammation.
Founded
2018
Focus
Small Molecules
About
TheraCryf is a clinical drug development company developing sulforaphane-based medicines focused on the treatment of cancer and inflammation.
Company Info
TypePrivate
Founded2018
LocationLondon, United Kingdom
StagePhase 1
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile